Combined criteria for dose optimisation in early phase clinical trials (Q6625215)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Combined criteria for dose optimisation in early phase clinical trials |
scientific article; zbMATH DE number 7932711
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Combined criteria for dose optimisation in early phase clinical trials |
scientific article; zbMATH DE number 7932711 |
Statements
Combined criteria for dose optimisation in early phase clinical trials (English)
0 references
28 October 2024
0 references
adaptive design
0 references
continuation ratio model
0 references
\(D\)-optimum design
0 references
penalty function
0 references
phase I/II trial
0 references
0 references
0 references
